ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYZK4776
Stock Name / FundiShares Healthcare Innovation UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerDRDR(GBX) LSE
ETF Ticker2B78(EUR) F
ETF Ticker2B78.DE(EUR) CXE
ETF TickerDRDR.LS(GBX) CXE
ETF TickerHEAL.AS(EUR) CXE
ETF TickerHEAL.LS(USD) CXE
ETF TickerHEALz(USD) CXE
ETF TickerHEAL(EUR) ETF Plus
ETF TickerDRDR.L(GBP) LSE

Holdings detail for SUPN

Stock NameSupernus Pharmaceuticals Inc
TickerSUPN(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS8684591089
LEI549300GRM36VBKISYJ58

Show aggregate SUPN holdings

News associated with SUPN

Contrasting Supernus Pharmaceuticals (NASDAQ:SUPN) and Evoke Pharma (NASDAQ:EVOK)
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) and Evoke Pharma (NASDAQ:EVOK – Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Volatility & Risk Supernus Pharmaceuticals has a beta […] - 2025-09-04 02:30:48
Supernus Pharmaceuticals (NASDAQ:SUPN) Raised to “Hold” at Zacks Research
Zacks Research upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a strong sell rating to a hold rating in a research report sent to investors on Tuesday morning,Zacks.com reports. Several other analysts also recently weighed in on SUPN. Cantor Fitzgerald boosted their target price on Supernus Pharmaceuticals from $42.00 to $46.00 and gave […] - 2025-08-22 03:08:51
Maryland State Retirement & Pension System Trims Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Maryland State Retirement & Pension System lessened its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 13.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 16,094 shares of the specialty pharmaceutical company’s stock after selling 2,514 shares during […] - 2025-08-15 04:51:00
Supernus Pharmaceuticals (NASDAQ:SUPN) Reaches New 1-Year High on Analyst Upgrade
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Get Free Report)’s share price hit a new 52-week high on Wednesday after Cantor Fitzgerald raised their price target on the stock from $42.00 to $46.00. Cantor Fitzgerald currently has an overweight rating on the stock. Supernus Pharmaceuticals traded as high as $41.51 and last traded at $42.29, with a […] - 2025-08-08 02:19:00
SUPN Crosses Above Average Analyst Target
In recent trading, shares of Supernus Pharmaceuticals Inc (Symbol: SUPN) have crossed above the average analyst 12-month target price of $40.20, changing hands for $42.44/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: down - 2025-08-07 12:32:22
Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded at Wall Street Zen
Wall Street Zen upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a research note released on Saturday morning. Separately, Cantor Fitzgerald raised shares of Supernus Pharmaceuticals from a “neutral” rating to an “overweight” rating and set a $42.00 price objective for the company in a […] - 2025-08-05 02:56:51
Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Lowered by Wall Street Zen
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “buy” rating to a “hold” rating in a research note issued to investors on Sunday. Supernus Pharmaceuticals Stock Performance Shares of Supernus Pharmaceuticals stock opened at $33.23 on Friday. The firm has a fifty day moving average […] - 2025-07-22 02:55:51
Allspring Global Investments Holdings LLC Reduces Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Allspring Global Investments Holdings LLC lessened its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 6.5% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 19,353 shares of the specialty pharmaceutical company’s stock after selling 1,356 shares during the quarter. […] - 2025-07-10 04:34:50
Robeco Institutional Asset Management B.V. Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Robeco Institutional Asset Management B.V. bought a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 8,151 shares of the specialty pharmaceutical company’s stock, valued at approximately $267,000. Other […] - 2025-07-03 05:08:49
Illinois Municipal Retirement Fund Has $927,000 Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Illinois Municipal Retirement Fund decreased its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 2.5% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 28,303 shares of the specialty pharmaceutical company’s stock after selling 730 shares […] - 2025-07-02 05:28:54
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Stake Boosted by Exchange Traded Concepts LLC
Exchange Traded Concepts LLC increased its stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 12.5% during the first quarter, HoldingsChannel reports. The firm owned 24,881 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,762 shares during the period. Exchange Traded Concepts LLC’s holdings in Supernus Pharmaceuticals were worth $815,000 at […] - 2025-06-20 05:21:54
Azzad Asset Management Inc. ADV Acquires New Stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Azzad Asset Management Inc. ADV acquired a new stake in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,847 shares of the specialty pharmaceutical company’s stock, valued at approximately $552,000. A number of other […] - 2025-06-16 05:40:53
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Bought by Versant Capital Management Inc
Versant Capital Management Inc grew its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 6,931.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,125 shares of the specialty pharmaceutical company’s stock after purchasing an additional […] - 2025-06-06 05:45:08
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 19,824 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 24.7% during the 4th quarter, Holdings Channel reports. The firm owned 100,020 shares of the specialty pharmaceutical company’s stock after buying an additional 19,824 shares during the period. UBS […] - 2025-06-05 05:10:54
Millennium Management LLC Sells 222,273 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Millennium Management LLC decreased its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 87.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 30,470 shares of the specialty pharmaceutical company’s stock after selling 222,273 shares during […] - 2025-06-05 04:25:01
Squarepoint Ops LLC Sells 475 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Squarepoint Ops LLC cut its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 2.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 20,492 shares of the specialty pharmaceutical company’s stock after selling 475 shares during the period. Squarepoint Ops LLC’s holdings in Supernus Pharmaceuticals were worth $741,000 at the end of […] - 2025-06-03 05:04:50
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Acquires 1,083 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 3.9% in the fourth quarter, HoldingsChannel.com reports. The fund owned 28,563 shares of the specialty pharmaceutical company’s stock after buying an additional 1,083 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Supernus Pharmaceuticals […] - 2025-05-26 04:47:00
Graham Capital Management L.P. Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Graham Capital Management L.P. bought a new position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 6,908 shares of the specialty pharmaceutical company’s stock, valued at approximately $250,000. […] - 2025-05-19 05:26:49
Supernus Pharmaceuticals (NASDAQ:SUPN) Upgraded at StockNews.com
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a buy rating to a strong-buy rating in a research note published on Friday. Separately, Cantor Fitzgerald reiterated a “neutral” rating and set a $36.00 price objective on shares of Supernus Pharmaceuticals in a research note on Wednesday, February 26th. Get Our Latest Stock […] - 2025-05-19 02:38:47
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Acquired by Northern Trust Corp
Northern Trust Corp boosted its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.3% in the fourth quarter, HoldingsChannel reports. The firm owned 717,161 shares of the specialty pharmaceutical company’s stock after purchasing an additional 110,867 shares during the quarter. Northern Trust Corp’s holdings in Supernus Pharmaceuticals were worth $25,933,000 as […] - 2025-05-12 04:49:02
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Shares Sold by First Trust Advisors LP
First Trust Advisors LP lessened its stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 48.1% in the 4th quarter, Holdings Channel reports. The firm owned 27,019 shares of the specialty pharmaceutical company’s stock after selling 25,048 shares during the period. First Trust Advisors LP’s holdings in Supernus Pharmaceuticals were worth $977,000 […] - 2025-05-08 04:44:59
Barclays PLC Purchases 14,061 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Barclays PLC increased its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 12.9% in the fourth quarter, Holdings Channel.com reports. The institutional investor owned 122,849 shares of the specialty pharmaceutical company’s stock after buying an additional 14,061 shares during the period. Barclays PLC’s holdings in Supernus Pharmaceuticals were worth $4,442,000 at […] - 2025-04-28 04:59:03
Raymond James Financial Inc. Takes Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Raymond James Financial Inc. bought a new stake in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 189,364 shares of the specialty pharmaceutical company’s stock, valued at approximately $6,847,000. Raymond James Financial Inc. owned approximately […] - 2025-04-24 04:41:05
Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) Position Raised by Invesco Ltd.
Invesco Ltd. lifted its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 4.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 508,069 shares of the specialty pharmaceutical company’s stock after acquiring an additional 22,027 shares during the period. Invesco Ltd. owned 0.92% of […] - 2025-04-20 05:22:48
JPMorgan Chase & Co. Acquires 44,414 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
JPMorgan Chase & Co. grew its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 17.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 297,810 shares of the specialty pharmaceutical company’s stock after purchasing an additional 44,414 shares during the quarter. […] - 2025-04-15 04:32:48
Arrowstreet Capital Limited Partnership Purchases 77,393 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Arrowstreet Capital Limited Partnership increased its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 79.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 174,916 shares of the specialty pharmaceutical company’s stock after acquiring an additional 77,393 shares during […] - 2025-04-08 05:01:05
Prudential Financial Inc. Has $2.37 Million Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Prudential Financial Inc. grew its position in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 14.3% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 66,733 shares of the specialty pharmaceutical company’s stock after buying an additional 8,352 shares […] - 2025-04-04 04:37:01
Sei Investments Co. Sells 16,825 Shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Sei Investments Co. cut its holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 5.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 296,915 shares of the specialty pharmaceutical company’s stock after selling 16,825 shares during the period. Sei Investments Co.’s holdings in Supernus Pharmaceuticals were worth $10,736,000 at the end of […] - 2025-03-30 05:37:02
Swiss National Bank Has $3.92 Million Stock Position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)
Swiss National Bank lifted its position in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 0.7% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 108,400 shares of the specialty pharmaceutical company’s stock after purchasing an additional 800 shares during the quarter. […] - 2025-03-26 05:44:46
Supernus Pharmaceuticals (NASDAQ:SUPN) Stock Rating Lowered by StockNews.com
Supernus Pharmaceuticals (NASDAQ:SUPN – Get Free Report) was downgraded by StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued on Monday. Separately, Cantor Fitzgerald reiterated a “neutral” rating and issued a $36.00 price objective on shares of Supernus Pharmaceuticals in a research note on Wednesday, February 26th. Get Our Latest […] - 2025-03-26 03:58:55

iShares Healthcare Innovation UCITS ETF USD (Acc) SUPN holdings

DateNumber of SUPN Shares HeldBase Market Value of SUPN SharesLocal Market Value of SUPN SharesChange in SUPN Shares HeldChange in SUPN Base ValueCurrent Price per SUPN Share HeldPrevious Price per SUPN Share Held
2025-11-27 (Thursday)67,872USD 3,139,759USD 3,139,7590USD 0 USD 46.26 USD 46.26
2025-11-26 (Wednesday)67,872USD 3,139,759SUPN holding increased by 12217USD 3,139,7590USD 12,217 USD 46.26 USD 46.08
2025-11-25 (Tuesday)67,872USD 3,127,542SUPN holding increased by 63121USD 3,127,5420USD 63,121 USD 46.08 USD 45.15
2025-11-24 (Monday)67,872USD 3,064,421SUPN holding decreased by -11538USD 3,064,4210USD -11,538 USD 45.15 USD 45.32
2025-11-21 (Friday)67,872USD 3,075,959SUPN holding increased by 35972USD 3,075,9590USD 35,972 USD 45.32 USD 44.79
2025-11-20 (Thursday)67,872USD 3,039,987SUPN holding decreased by -61763USD 3,039,9870USD -61,763 USD 44.79 USD 45.7
2025-11-19 (Wednesday)67,872USD 3,101,750SUPN holding increased by 54297USD 3,101,7500USD 54,297 USD 45.7 USD 44.9
2025-11-18 (Tuesday)67,872USD 3,047,453SUPN holding decreased by -12895USD 3,047,4530USD -12,895 USD 44.9 USD 45.09
2025-11-17 (Monday)67,872USD 3,060,348SUPN holding increased by 6108USD 3,060,3480USD 6,108 USD 45.09 USD 45
2025-11-14 (Friday)67,872SUPN holding decreased by -606USD 3,054,240SUPN holding increased by 11078USD 3,054,240-606USD 11,078 USD 45 USD 44.44
2025-11-13 (Thursday)68,478USD 3,043,162SUPN holding decreased by -12326USD 3,043,1620USD -12,326 USD 44.44 USD 44.62
2025-11-12 (Wednesday)68,478USD 3,055,488SUPN holding decreased by -102033USD 3,055,4880USD -102,033 USD 44.62 USD 46.11
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of SUPN by Blackrock for IE00BYZK4776

Show aggregate share trades of SUPN

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-14SELL-606 45.000* 36.85 Profit of 22,328 on sale
2025-10-24SELL-58052.83053.280 53.235USD -30,876 35.71 Loss of -10,166 on sale
2025-09-11BUY29146.66046.720 46.714USD 13,594 34.15
2025-07-08SELL-29132.09032.720 32.657USD -9,503 33.86 Profit of 349 on sale
2025-06-24SELL-29331.67032.670 32.570USD -9,543 34.00 Profit of 420 on sale
2025-06-23SELL-29331.99032.490 32.440USD -9,505 34.02 Profit of 463 on sale
2025-06-20BUY2,25732.28033.300 33.198USD 74,928 34.03
2025-06-11SELL-28233.15033.660 33.609USD -9,478 34.10 Profit of 140 on sale
2025-05-30SELL-28331.70031.900 31.880USD -9,022 34.21 Profit of 659 on sale
2025-05-21BUY28332.63033.160 33.107USD 9,369 34.33
2025-05-14SELL-1,69231.54032.350 32.269USD -54,599 34.40 Profit of 3,598 on sale
2025-04-30SELL-28232.48032.800 32.768USD -9,241 34.62 Profit of 522 on sale
2025-04-28SELL-28232.25032.570 32.538USD -9,176 34.67 Profit of 600 on sale
2025-04-25SELL-28232.22032.360 32.346USD -9,122 34.69 Profit of 661 on sale
2025-04-11SELL-1,70431.67031.680 31.679USD -53,981 35.01 Profit of 5,684 on sale
2025-04-08SELL-84930.64033.140 32.890USD -27,924 35.15 Profit of 1,917 on sale
2025-04-07SELL-59832.27034.260 34.061USD -20,368 35.18 Profit of 670 on sale
2025-03-31SELL-56632.75032.870 32.858USD -18,598 35.31 Profit of 1,389 on sale
2025-03-21SELL-56432.15032.900 32.825USD -18,513 35.54 Profit of 1,529 on sale
2025-03-12SELL-28531.38031.980 31.920USD -9,097 35.91 Profit of 1,138 on sale
2025-02-28SELL-28532.06032.080 32.078USD -9,142 36.42 Profit of 1,239 on sale
2025-02-25BUY28532.81033.500 33.431USD 9,528 36.64
2025-02-20SELL-28434.59034.620 34.617USD -9,831 36.82 Profit of 626 on sale
2025-02-19BUY56833.52035.360 35.176USD 19,980 36.88
2025-02-18BUY28439.75039.990 39.966USD 11,350 36.83
2024-12-30BUY1,72636.91037.280 37.243USD 64,281 35.73
2024-12-06SELL-27337.17037.480 37.449USD -10,224 35.62 Loss of -499 on sale
2024-12-04SELL-27337.15037.520 37.483USD -10,233 35.52 Loss of -536 on sale
2024-12-03SELL-54637.03037.240 37.219USD -20,322 35.46 Loss of -959 on sale
2024-11-21SELL-27535.82036.530 36.459USD -10,026 35.02 Loss of -396 on sale
2024-11-20SELL-28036.12036.500 36.462USD -10,209 34.96 Loss of -421 on sale
2024-11-19SELL-28035.53035.640 35.629USD -9,976 34.92 Loss of -198 on sale
2024-11-18SELL-1,09635.25036.200 36.105USD -39,571 34.90 Loss of -1,317 on sale
2024-11-12SELL-27437.83037.990 37.974USD -10,405 34.71 Loss of -895 on sale
2024-11-07SELL-27436.40037.750 37.615USD -10,307 34.43 Loss of -872 on sale
2024-11-05SELL-54834.74039.370 38.907USD -21,321 34.10 Loss of -2,633 on sale
2024-10-28SELL-27434.16034.680 34.628USD -9,488 33.80 Loss of -228 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of SUPN

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19122,1513301,18840.6%
2025-09-18121,7610267,52545.5%
2025-09-1770,393750204,21134.5%
2025-09-1692,8030275,02433.7%
2025-09-15117,876210292,58040.3%
2025-09-1256,904200164,68934.6%
2025-09-1180,78550192,70641.9%
2025-09-1097,2060247,18239.3%
2025-09-09103,40321,544214,67548.2%
2025-09-0894,0301,712217,57143.2%
2025-09-0565,260300193,61133.7%
2025-09-0487,4799,555199,60343.8%
2025-09-0371,5531,695171,33341.8%
2025-09-02151,60032,060318,69847.6%
2025-08-2978,3442,289147,46753.1%
2025-08-2896,124974162,32859.2%
2025-08-2798,4244,105244,87540.2%
2025-08-2668,3820134,61050.8%
2025-08-25114,0932,502258,41544.2%
2025-08-22170,4587,565320,38553.2%
2025-08-21126,8771,383256,89649.4%
2025-08-2097,552696267,86636.4%
2025-08-1996,5005,963208,44446.3%
2025-08-18104,7711,006285,51036.7%
2025-08-15124,03620,531334,97737.0%
2025-08-1483,0364,471360,72523.0%
2025-08-13143,7964,486408,81035.2%
2025-08-12120,422909359,23133.5%
2025-08-11112,8106,919330,27234.2%
2025-08-08228,44958,762395,64057.7%
2025-08-07334,0140923,64436.2%
2025-08-06692,0716,1101,667,36241.5%
2025-08-05248,6500476,50952.2%
2025-08-04162,9890229,99770.9%
2025-08-01250,1790326,68476.6%
2025-07-31433,277375912,33647.5%
2025-07-30158,3605215,82673.4%
2025-07-29188,5610455,53841.4%
2025-07-28160,9300241,81666.6%
2025-07-2598,8530302,32832.7%
2025-07-24122,0570194,07162.9%
2025-07-2362,1900125,50949.6%
2025-07-22141,5161,325343,16241.2%
2025-07-21197,0890471,96241.8%
2025-07-18105,7060300,27935.2%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.